Different Effects of Three Recruitment Maneuvers on the Lung Heterogeneity of Acute Respiratory Distress Syndrome
Launched by SOUTHEAST UNIVERSITY, CHINA · Mar 12, 2015
Trial Information
Current as of August 11, 2025
Unknown status
Keywords
ClinConnect Summary
Acute respiratory distress syndrome (ARDS) is the common disease in clinical,which pathophysiology is a lot of alveolar collapse and heterogeneity. Recruitment maneuver is one of the important therapy for improvement of this phenomenon. The previous research focuses on the hemodynamic and oxygenation effect of recruitment maneuver on the lung of ARDS. Seldom investigators try to find the intuitive change of heterogeneity when recruitment maneuver is implemented. In this study, the investigators compare three recruitment maneuvers on the lung heterogeneity of ARDS.
Electrical impedance tomo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who are severe or moderate ARDS
- • Patients who have signed ICF
- Exclusion Criteria:
- • Patients who are younger than 18 years old or older than 75 years old
- • Patients whose vital signs are unstable
- • Patients who are in other clinical trails
- • Patients who are pregnant
About Southeast University, China
Southeast University, located in Nanjing, China, is a prestigious institution renowned for its commitment to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university leverages its robust academic resources and state-of-the-art facilities to conduct clinical trials that aim to address pressing healthcare challenges. Southeast University actively engages in partnerships with healthcare organizations and industry leaders to facilitate cutting-edge research, enhance patient outcomes, and contribute to the global medical community. Through its dedicated focus on ethical standards and scientific rigor, Southeast University is poised to make significant contributions to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nanjing, Jiangsu, China
Patients applied
Trial Officials
Yingzi Huang
Study Director
southeast univerity, China
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials